A B C D E F G H I J K L M N O P Q R S T U

Core Reimbursement Dossier

Core Reimbursement Dossier

A Core Reimbursement Dossier is a crucial document submitted during the late stage of product development to be considered for reimbursement by healthcare payers and regulatory authorities. It is a key component of the core value dossier, providing comprehensive information to support the clinical, economic, and humanistic value of a new medical intervention or product. The Core Reimbursement Dossier presents essential evidence and data to demonstrate the product’s efficacy, cost-effectiveness, and overall value in addressing a specific therapeutic area’s global burden of illness.

 

Core Reimbursement Dossier plays a vital role in securing reimbursement for new medical interventions and products. By providing robust evidence of clinical, economic, and humanistic value, it demonstrates the product’s potential to positively impact patient care and healthcare resource allocation. The successful reimbursement of a product enables greater patient access and ensures that innovative medical interventions can reach those who can benefit from them the most.

Other definitions

Contact our experts today

Composed of proven experts from the pharmaceutical industry, our team is ready to answer to your needs in any
area of product development, commercialisation and early access programs, and life cycle management

Language